BioSpace News Archive

Global Cord Blood Corporation today announced that it plans to release financial results for the first quarter fiscal 2022 on Monday, August 30, 2021, after the market close.

CTI BioPharma Corp. today announced transactions totaling up to $135 million in funding for CTI, with $50 million in secured debt to be funded at closing and $60 million to purchase a tiered royalty on sales of pacrinitib upon product approval of pacrinitib by the U.S. Food and Drug Administration (FDA).

Precision BioSciences to Host In Vivo Gene Editing R&D Event on September 9, 2021

Frontiers in Digital Health recently published a longitudinal study designed to evaluate digital musculoskeletal (MSK) program usage and outcomes by generation.

Kintor Pharmaceutical Limited today announced that it has entered into a licensing agreement with PT Etana Biotechnologies Indonesia, on the commercialization of proxalutamide

LianBio today announced the first patient has been treated in a Phase 2a clinical trial of infigratinib in patients with locally advanced or metastatic gastric cancer

NeoDynamics AB today announced that the Company has been granted a U.S. patent for its needle design employed in the NeoNavia FlexiPulse probe.

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), today announced that a recent independent study out of Stanford University’s School of Medicine, published in PRS Global Open, has confirmed that the Sientra® AlloX2® dual port tissue expander enables efficient management of seroma and early targeted intervention in prepectoral breast reconstruction.

IBSA Pharma Inc. is introducing three new dosage strengths of its Tirosint®-SOL (levothyroxine sodium) oral solution to treat hypothyroidism.

Forge Biologics announced today the expansion of its leadership team with two key hires in process development and medical affairs.